Overexpressed lysosome-associated protein transmembrane 4 beta is associated with prostate cancer

Jia Guo,Xiuheng Liu,Min Wang,Zhishun Wang

DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2015.12.015

2015-01-01

Abstract:Objective To analyze the expression of lysosome-associated protein transmembrane 4 beta (LAPTM4B) in prostate tissues and investigate the relationship with clinicopathological variables in prostate cancer.Methods Use available microarray datasets to test the expression of LAPTM4B in prostate tissues.In 100 prostate cancer (PCa) and 80 benign prostatic hyperplasia (BPH) samples, we performed immunohistochemical staining to validate expression of LAPTM4B.Results Microarray data indicated that that LAPTM4B DNA copy number was significantly increased in PCa tissues relative to normal prostate tissues (P ＜ 0.01).Similarly, increased LAPTM4B DNA copy number was found in metastatic PCa (P ＜ 0.01).mRNA level of LAPTM4B is significantly over-expressed in patients with higher Gleason score (P ＜ 0.05).LAPTM4B protein was overexpressed in PCa tissues compared with the BPH (P ＜0.01).LAPTM4B protein expression was significantly upregulated in PCa patients with, higher preoperative prostate specific antigen (PSA, P ＜ 0.01);in patients of higher Gleason score LAPTM4B protein was significantly increased (P ＜ 0.01), and in patients with BCR LAPTM4B protein expression was significantly higher (P ＜0.05).Conclusion Overexpressed LAPTM4B is associated with some PCa clinicopathological variables and is a potential PCa molecular marker.